Objective: To study the clinical effect of combined with low molecular weight heparin sodium in the treatment of acute cerebral infarction with cerebral infarction and depression, and to study the clinical effect of low molecular weight heparin sodium in the treatment of acute cerebral infarction. Methods: Using in our hospital from January 2013 to 2015 January acute cerebral infarction complicated with depression in patients with 96 cases, using random number table method will 96 cases at acute stage of cerebral infarction complicated with depression were divided into observation group (48 cases) and control group (48 cases); observation group taking oral salvianolic acid calcium combined with low molecular weight heparin sodium treatment, the control group took single oral low molecular weight heparin sodium treatment, the clinical curative effect of two groups of patients and blood lipid levels were observed and compared and subjected to further analysis. Results the clinical effective rate of the observation group was 91.67 (44/48), the clinical effective rate of the control group was 75% (36/48), the difference was statistically significant (P < 0.05). There was no significant difference in HAMA score and HAMD score before treatment (P>0.05); the difference between the two scores and the scores of the treatment group was significantly higher (P<0.05).Conclusion : Combined with low molecular weight heparin sodium for treatment of cerebral infarction and depression, it has a certain safety, so it is worthy of clinical recommendation.
Key words： Low molecular weight heparin; low molecular weight heparin sodium; cerebral infarction; depression